Why Is Myrbetriq So Hard to Find? [Explained for 2026]

If you've recently walked up to a pharmacy counter only to be told your Myrbetriq prescription can't be filled, you're not alone. Many patients with overactive bladder (OAB) report sporadic difficulty finding this medication at their usual pharmacy. So what's going on — and what can you do about it?

What Is Myrbetriq and Who Uses It?

Myrbetriq (mirabegron) is a prescription medication approved by the FDA in 2012 to treat overactive bladder in adults. Unlike older OAB medications — which block nerve signals in the bladder — Myrbetriq works as a beta-3 adrenergic agonist, relaxing the bladder muscle so it can hold more urine. This different mechanism means it tends to cause fewer of the classic anticholinergic side effects like dry mouth and constipation that plague older drugs.

It's also FDA-approved for neurogenic detrusor overactivity (NDO) in children ages 3 and older. Millions of patients depend on it daily. When supply becomes patchy, it creates real disruption for people managing a chronic condition.

Is There an Official Myrbetriq Shortage in 2026?

As of 2026, Myrbetriq is not listed on the FDA's official drug shortage database. That's generally good news — it means the overall supply chain for mirabegron is not critically disrupted at a national level. However, "no official shortage" doesn't mean every pharmacy in every city has it readily stocked. Pharmacy inventory is managed locally, and a drug can be in short supply at your neighborhood CVS while sitting on shelves at a Walmart across town.

Brand-name Myrbetriq is manufactured by Astellas Pharma US, Inc. Its supply chain has historically been stable. The more recent complexity comes from the generic landscape.

Why Generic Mirabegron Has a Complicated History

The generic version of Myrbetriq — simply called mirabegron extended-release — entered the U.S. market in early 2024 after years of patent litigation. Astellas challenged generic manufacturers Lupin and Zydus in court, and a temporary federal injunction briefly halted their generic launches in April 2024. A subsequent federal court ruling in April 2025 blocked those specific manufacturers from selling their versions based on patent infringement claims.

What this means practically: the generic landscape is still evolving. Some manufacturers have FDA approval but may face restrictions on selling. This can create inconsistent generic availability depending on which manufacturer your pharmacy sources from. If your pharmacy switched from one generic supplier to another — or ran out of their usual generic — your refill may hit a wall.

Top Reasons Myrbetriq May Be Out of Stock Near You

Even without a formal FDA shortage, several real-world factors contribute to Myrbetriq being hard to fill:

• Ongoing patent litigation disrupting generic supply. Court battles have repeatedly reshuffled which manufacturers can legally sell mirabegron generics in the U.S., creating supply gaps.
• Pharmacy ordering patterns. Small independent pharmacies often stock limited quantities of specialty OAB drugs. If several patients fill at once, they may run low.
• Insurance step therapy requirements. UnitedHealthcare implemented step therapy for mirabegron in late 2025, requiring patients to try two other OAB drugs first before coverage kicks in. This creates delays and prescription confusion.
• Formulary switches and prior authorization. When insurance plans reclassify Myrbetriq or its generic, pharmacists may need updated prior authorization paperwork before they can dispense.
• High cost of brand-name Myrbetriq. At $457+ for 30 tablets without insurance, many pharmacies don't keep large quantities of brand-name Myrbetriq on hand, preferring to order it specially.

What Should You Do If You Can't Find Myrbetriq?

Don't just give up at the first pharmacy that says no. Here's a practical action plan:

1. Call multiple pharmacies. Ask specifically about both brand Myrbetriq and generic mirabegron — they may have one but not the other.
2. Ask your pharmacist to special order it. Many pharmacies can order Myrbetriq within 1-2 business days if it's not currently on their shelf.
3. Contact your prescriber about a temporary alternative OAB medication if supply is unavailable for an extended period. Options like oxybutynin, tolterodine, or solifenacin may be covered while you wait.
4. Use medfinder. Rather than calling pharmacies yourself, medfinder does the legwork for you — calling pharmacies near your location to check which ones can fill your Myrbetriq prescription right now.

How medfinder Helps Patients Find Myrbetriq

When your pharmacy says "out of stock," the last thing you want to do is spend your afternoon calling pharmacy after pharmacy. medfinder is a paid service that does exactly that — you provide your medication, dose, and zip code, and medfinder contacts local pharmacies on your behalf to identify which ones have Myrbetriq in stock. Results are texted directly to you.

It's especially useful when you're dealing with the inconsistent availability caused by Myrbetriq's evolving generic market and pharmacy-level stocking decisions.

Will Myrbetriq Get Easier to Find?

The generic mirabegron market is likely to stabilize over time as patent disputes resolve and more manufacturers enter the market. Generic mirabegron from Alkem and other approved manufacturers is already available at many pharmacies. As insurance plans add generic mirabegron to more favorable formulary tiers and step therapy protocols become more standardized, access should improve. For now, knowing your options and acting proactively when a fill fails is the best strategy.

Related Articles

For more guidance, see How to Find Myrbetriq in Stock Near You and Myrbetriq Shortage Update 2026.